Uppsala, Sweden – July 31, 2014 - The number of shares and votes in Orexo AB has changed as a result of the exercise of warrants in connection with the company’s incentive programs. Today, the last trading day of the month, there are in total 32,953,233 shares and votes in the company. For further information, please contact: Henrik Juuel, EVP and Chief Financial Officer Tel: +46 (0)18-780 88 00, E-mail: ir@orexo.com About Orexo Orexo is a specialty pharma company with commercial operations in the United States and R&D in Sweden developing improved treatments using proprietary drug delivery technology and commercial operations in the United States. The company is commercializing its proprietary product, ZUBSOLV® sublingual tablets, for maintenance treatment of opioid dependence, in the United States. The ZUBSOLV® sublingual tablet is a novel formulation of buprenorphine and naloxone using Orexo’s extensive knowledge in sublingual technologies. Orexo has a portfolio of two approved and revenue generating products currently marketed under license in the US, EU and Japan. Orexo AB, with its headquarters in Sweden, is listed on NASDAQ OMX Stockholm Exchange and its American Depositary Receipts (ADRs) trade on the OTCQX marketplace in the U.S. under the symbol, “ORXOY”. The largest shareholders are Novo A/S and HealthCap. For information about Orexo please visit www.orexo.com Orexo AB (publ) discloses the information provided herein pursuant to the Financial Instruments Trading Act and/or the Securities Markets Act. The information was submitted for publication at 5:30 pm CET on July 31, 2014.
Number of shares and votes in Orexo Uppsala, Sweden –
Top 10 Most Recent News Articles
Trading Platforms Poised for Billions by 2031
Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....
Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?
Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...
Continue Reading
Kal Plastics Showcases at Design-2-Part Expo
Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...
Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook
Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...
Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts
The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...
Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin
Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...
Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands
Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...
Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk
Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...
Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad
Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...
Continue ReadingTop 5 Most Recently Viewed Articles
Stablecoins Surging: Key Players and Market Impacts Explored
The Rise of Stablecoins in the Financial World Stablecoins are reshaping the global financial landscape, experiencing remarkable growth and increasing importance. Recently, their supply has reached an all-time high of $170 billion, and the monthly settlement volumes now exceed $1.4 trillion as of mid-2024. Key Insights from Analysts Experts have observed that stablecoins...
Continue Reading
CoRegen, Inc. Welcomes Dr. Sonal Gupta as CMO to Revolutionize Cancer Treatment
CoRegen, Inc. Welcomes Dr. Sonal Gupta as Chief Medical Officer CoRegen, a progressive biopharmaceutical company known for tackling some of the toughest cancer types, proudly shares the appointment of Sonal Gupta, M.D., Ph.D., as its Chief Medical Officer (CMO). With a focus on revolutionizing treatment methods, Dr. Gupta's role will be pivotal in implementing advanced...
Continue Reading
Understanding Coupang's Recent Short Interest Trends
Analyzing Recent Trends in Coupang's Short Interest Coupang (CPNG) has recently seen a notable reduction in its short interest. Specifically, the short percent of float has dropped by 11.11% since the last reporting period. Currently, there are 14.30 million shares sold short, which constitutes 1.44% of the total regular shares available for trading. Based on the...
Continue Reading
Saia Reports LTL Shipment Insights and Trends for Second Quarter
Understanding Saia's LTL Shipment Performance Saia, Inc. (NASDAQ: SAIA), an established leader in the transportation sector, has released intriguing data regarding their less-than-truckload (LTL) services for the second quarter. The company's reports indicate a nuanced but telling shift in operations, highlighting how market dynamics are playing a role in their shipment...
Continue Reading
Insider Selling Trend: Randall K Fields Moves $159K in Stock
Randall K Fields Takes Major Step with ReposiTrak Recently, Randall K Fields, the Chief Executive Officer at ReposiTrak (TRAK), revealed plans for his stock holdings by executing a significant insider sale. This transaction, categorized in the latest SEC filing, saw Fields selling 7,500 shares valued at approximately $159,360. As the stock market changes daily, ReposiTrak...
Continue Reading